Advertisement

Purpuras

  • Torello M. LottiEmail author
  • Lara Tripo
  • Alice Garzitto
  • Aldona Pietrzak
  • Ilaria Ghersetich

Abstract

Purpura is a disease entity characterised by macules. By definition, macules are flat skin lesions not raised above the surrounding skin. Purpura manifests as skin discoloration caused by extravasation of red blood cells.

Further Reading

  1. Anoop P. Immune thrombocytopenic purpura: historical perspective, current status, recent advances and future directions. Indian Pediatr. 2012;49(10):811–8.PubMedGoogle Scholar
  2. Burge S. The management of cutaneous vasculitis. In: Panconesi E, editor. Dermatology in Europe. Oxford: Blackwell Scientific Publications; 1991. p. 328–30.Google Scholar
  3. Carlson JA, Chen KR. Cutaneous pseudovasculitis. Am J Dermatopathol. 2007a;29(1):44–55.PubMedGoogle Scholar
  4. Carlson JA, Chen KR. Cutaneous vasculitis update: neutrophilic muscular vessel and eosinophilic, granulomatous, and lymphocytic vasculitis syndromes. Am J Dermatopathol. 2007b;29(1):32–43.PubMedGoogle Scholar
  5. Carlson JA, Cavaliere LF, Grant-Kels JM. Cutaneous vasculitis: diagnosis and management. Clin Dermatol. 2006;24(5):414–29.PubMedGoogle Scholar
  6. Chen KR. Cutaneous vascular diseases. In: Tamaki K, Kimura T, editors. Comprehensive handbook of clinical dermatology. Tokyo: Nakayama-Shoten Co.; 2004.Google Scholar
  7. Chen KR, Carlson JA. Clinical approach to cutaneous vasculitis. Am J Clin Dermatol. 2008;9(2):71–92.PubMedGoogle Scholar
  8. Comacchi C, Ghersetich I, Lotti T. La vasculite necrotizzante cutanea. G Ital Dermatol Venereol. 1998;133:23–49.Google Scholar
  9. Cornacchi C, Ghersetich I, Lotti T. Le porpore pigmentarie croniche. G Ital Dermatol Venereol. 1994;129:69–78.Google Scholar
  10. D’Orazio JA, Neely J, Farhoudi N. ITP in children: pathophysiology and current treatment approaches. J Pediatr Hematol Oncol. 2013;35(1):1–13.PubMedGoogle Scholar
  11. Fathy H, Abdelgaber S. Treatment of pigmented purpuric dermatoses with narrow-band UVB: a report of six cases. J Eur Acad Dermatol Venereol. 2011;25(5):603–6.PubMedGoogle Scholar
  12. Ghersetich I, Lotti T, Bacci S, Comacchi C, Campanile G, Romagnoli R. Cell infiltrate in progressive pigmented purpura (Schamberg’s disease): immunophenotype, adhesion receptors, and intercellular relationships. Int J Dermatol. 1995;34(12):846–50.PubMedGoogle Scholar
  13. Grau R. Pseudovasculitis: mechanisms of vascular injury and clinical spectrum. Curr Rheumatol Rep. 2002;4:83–9.PubMedGoogle Scholar
  14. Gwilliam NR, Lazar DA, Brandt ML, Mahoney Jr DH, Wesson DE, Mazziotti MV, Nuchtern JG, Lee TC. An analysis of outcomes and treatment costs for children undergoing splenectomy for chronic immune thrombocytopenia purpura. J Pediatr Surg. 2012;47(8):1537–41. doi: 10.1016/j.jpedsurg.2012.02.013.PubMedGoogle Scholar
  15. Haneke E. Über die diagnostische Aussage von Biopsien der kleinen Lippenspeicheldrüsen bei Mundtrockenheit. Dtsch Z Mund Kiefer Gesichtschir. 1981;5:2664.Google Scholar
  16. Haneke E. Exzision-und Biopsieverfahren. Z Hautkr. 1988a;63(Suppl):17–49.PubMedGoogle Scholar
  17. Haneke E. Reconstruction of the lateral nail fold after lateral longitudinal nail biopsy. In: Robins P, editor. Surgical gems in dermatology. New York: Journal Publishing Group; 1988b. p. 91–3.Google Scholar
  18. Haneke E. Variationen der Flaschenzugnaht. In: Mahrle G, Schulze H-J, Krieg T, editors. Fortschritte der Operativen und Onkologischen Derrnatologie 8: Wundheilung-Wundverschluß. Heidelberg: Springer; 1994. p. 158–64.Google Scholar
  19. Haneke E. Developments and techniques in general cutaneous surgery. In: Dahl MV, Lynch PJ, editors. Current opinion in dermatology, vol. 2. Philadelphia: Current Science; 1995. p. 129–36.Google Scholar
  20. Haneke E. Flachexzision von Nävuszellnävi. In: Garbe C, Rassner G, editors. Dermatologie—Leitlinien und Qualitätssicherung fur Diagnostik und Therapie. Berlin: Springer; 1998. p. 523–5.Google Scholar
  21. Haneke E. Operative Therapie akraler und subungualer Melanome. In: Rompel R, Petres J, editors. Operative and Onkologische Dermatologie. Fortschritte der Operativen and Onkologischen Dermatologie 15. Berlin: Springer; 1999. p. 210–4.Google Scholar
  22. Haneke E, Bübl R. Demonstration of immunoglobulins in the normal epithelium of the lip mucosa. Arch Dermatol Res. 1983;275:266.Google Scholar
  23. Journeycake JM. Childhood immune thrombocytopenia: role of rituximab, recombinant thrombopoietin, and other new therapeutics. Hematol Am Soc Hematol Educ Program. 2012;2012:444–9.Google Scholar
  24. Kano Y, Hirayama F, Orihara M. Successful treatment of Schamberg’s disease with pentoxifylline. J Am Acad Dermatol. 1997;36:827–30.PubMedGoogle Scholar
  25. Kawakami T. New algorithm (KAWAKAMI algorithm) to diagnose primary cutaneous vasculitis. J Dermatol. 2010;37:113–24.PubMedGoogle Scholar
  26. Krull EA, Zook EG, Baran R, Haneke E. Nail surgery. A text and Atlas. Philadelphia: Lippincott, Williams & Wilkins; 2001.Google Scholar
  27. Lapraik C, Watts R, Scott DG. Modern management of primary systemic vasculitis. Clin Med. 2007;7(1):43–7.Google Scholar
  28. Lotti T. The management of systemic complications of vasculitis. In: Panconesi E, editor. Dermatology in Europe. Oxford: Blackwell Scientific Publications; 1991. p. 330–2.Google Scholar
  29. Lotti T, Celasco G, Tsampau D, et al. Mesoglycan treatment restores defective fibrinolytic potential in cutaneous necrotizing venulitis. Int J Dermatol. 1993;32(5):368–71.PubMedGoogle Scholar
  30. Lotti T, Ghersetich I, Panconesi E. The purpuras. Int J Dermatol. 1994a;33(1):1–10.PubMedGoogle Scholar
  31. Lotti T, Ghersetich I, Panconesi E. Why should we use PUVA treatment in pigmented purpuric lichenoid dermatitis. J Am Acad Dermatol. 1994b;30(1):145.PubMedGoogle Scholar
  32. Lotti T, Comacchi C, Ghersetich I. Cutaneous necrotizing vasculitis. Int J Dermatol. 1996a;35:457–74.PubMedGoogle Scholar
  33. Lotti T, Ghersetich I, Comacchi C, Panconesi E. Purpuras and related conditions. J Eur Acad Dermatol Venereol. 1996b;7:1–25.Google Scholar
  34. Lotti T, Ghersetich I, Comacchi C, Jorizzo JL. Cutaneous small vessel vasculitis. J Am Acad Dermatol. 1998;39(5):667–87.PubMedGoogle Scholar
  35. Mathieson PW, Cobbold SP, Hale CG, et al. Monoclonal-antibody therapy in systemic vasculitis. N Engl J Med. 1990;323:250–4.PubMedGoogle Scholar
  36. Morgand M, Buffet M, Busson M, Loiseau P, Malot S, Amokrane K, Fortier C, London J, Bonmarchand G, Wynckel A, Provôt F, Poullin P, Vanhille P, Presne C, Bordessoule D, Girault S, Delmas Y, Hamidou M, Mousson C, Vigneau C, Lautrette A, Pourrat J, Galicier L, Azoulay E, Pène F, Mira JP, Rondeau E, Ojeda-Uribe M, Charron D, Maury E, Guidet B, Veyradier A, Tamouza R, Coppo P. High prevalence of infectious events in thrombotic thrombocytopenic purpura and genetic relationship with toll-like receptor 9 polymorphisms: experience of the French Thrombotic Microangiopathies Reference Center. Transfusion. 2014;54:389–97.PubMedGoogle Scholar
  37. Ryan TJ. Cutaneous vasculitis. In: Rook A et al., editors. Textbook of dermatology. Oxford: Blackwell Scientific Publications; 1992. p. 1893–961.Google Scholar
  38. Sardana K, Sarkar R, Sehgal VN. Pigmented purpuric dermatoses: an overview. Int J Dermatol. 2004;43:482–8.PubMedGoogle Scholar
  39. Sharma S, Sharma P, Tyler LN. Transfusion of blood and blood products: indications and complications. Am Fam Physician. 2011;83(6):719–24.PubMedGoogle Scholar
  40. Soter AN. Cutaneous necrotizing vasculitis. In: Freedberg IM, Eisen AZ, Wolff K, et al., editors. Dermatology in general medicine. 5th ed. New York: McGraw-Hill; 1999. p. 2044–53.Google Scholar
  41. Suresh E. Diagnostic approach to patients with suspected vasculitis. Postgrad Med J. 2006;82(970):483–8.PubMedPubMedCentralGoogle Scholar
  42. Tsampau D, Buggiani G, Hercogova J, Lotti T. Cutaneous necrotizing vasculitis: a rational therapeutic approach. Dermatol Ther. 2012;25(4):335–9.PubMedGoogle Scholar
  43. Verma P. Generalized pigmented purpuric dermatosis in a boy treated with narrow-band-ultraviolet B therapy. Pediatr Dermatol. 2012;30:e291–2.PubMedGoogle Scholar
  44. Zhao JY, Zhang RN, Duan XH, Xu ZL, Li HW, Gu FS. A case of systemic amyloidosis beginning with purpura. Chin Med J (Engl). 2012;125(3):555–7.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  • Torello M. Lotti
    • 1
    • 2
    Email author
  • Lara Tripo
    • 3
  • Alice Garzitto
    • 3
  • Aldona Pietrzak
    • 4
  • Ilaria Ghersetich
    • 3
  1. 1.University of Rome “G. Marconi”RomeItaly
  2. 2.Centro Studi per la Ricerca Multidisciplinare Rigenerativa (CSRMR)RomeItaly
  3. 3.Division of Dermatology, Department of Surgery and Translational MedicineUniversity of FlorenceFlorenceItaly
  4. 4.Department of Dermatology, Venereology and Paediatric DermatologyMedical University of LublinLublinPoland

Personalised recommendations